Retatrutide Shows Significant Weight Loss in Phase 3 Obesity Trial | Retatrutide News

Eli Lilly's retatrutide showed powerful weight loss results in a Phase 3 obesity trial. This highlights its potential as a new treatment option in the f...
Clinical Trials · October 13, 2026